American Healthcare REIT price target raised to $36 from $31 at BofA

BofA raised the firm’s price target on American Healthcare REIT (AHR) to $36 from $31 and keeps a Buy rating on the shares after the company delivered a Q3 beat and now expects FY24 earnings of $1.40-$1.43, a 13% midpoint increase above the firm and Street views. Total same-store NOI guidance was also increased to 16%, which the firm says it believes is conservative, while noting that the stock remains on BofA’s “US1 list.”